PUBLISHER: The Business Research Company | PRODUCT CODE: 2127360
PUBLISHER: The Business Research Company | PRODUCT CODE: 2127360
Lactobacillus fermentum is a beneficial probiotic bacterial species naturally present in the human digestive tract and in a variety of fermented foods, where it supports digestive function and helps maintain a balanced gut microbiome. It also generates lactic acid, which helps suppress harmful bacteria while promoting immune function and overall digestive health.
The primary types of lactobacillus fermentum include food-grade lactobacillus fermentum and pharmaceutical-grade lactobacillus fermentum. Food-grade lactobacillus fermentum refers to probiotic bacterial strains incorporated into food and nutritional products to promote gut health and support functional nutrition. These products are obtained from plant-based sources, dairy-based sources, and synthetic fermentation sources and are sold through online retail and offline retail channels. Their applications include probiotic supplements, functional foods and beverages, dairy products, dietary supplements, medical foods, therapeutic formulations, animal feed, and cosmetics and personal care products, serving end-use industries such as the food and beverage industry, pharmaceutical industry, nutraceutical industry, veterinary sector, cosmetics industry, and clinical sector.
Tariffs are influencing the lactobacillus fermentum market by increasing the cost of imported probiotic strains, fermentation systems, and essential raw material inputs required for producing food-grade and pharmaceutical-grade formulations. This is placing pressure on segments including probiotic supplements, functional foods and beverages, and therapeutic formulations, especially in regions that rely on international supply chains such as Asia-Pacific and Europe. Pharmaceutical and nutraceutical industries are facing higher costs and supply delays because of their dependence on specialized fermentation materials and clinical-grade cultures. However, tariffs are also stimulating local fermentation manufacturing, encouraging domestic strain development, and increasing regional production investments, which is strengthening supply chain resilience and accelerating localized probiotic innovation.
The lactobacillus fermentum market research report is one of a series of new reports from The Business Research Company that provides lactobacillus fermentum market statistics, including lactobacillus fermentum industry global market size, regional shares, competitors with a lactobacillus fermentum market share, detailed lactobacillus fermentum market segments, market trends and opportunities, and any further data you may need to thrive in the lactobacillus fermentum industry. This lactobacillus fermentum market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The lactobacillus fermentum market size has grown strongly in recent years. It will grow from $0.79 billion in 2025 to $0.87 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to traditional consumption of fermented foods in diets, increasing awareness of digestive health benefits of probiotics, growth of dairy based fermentation industries, expansion of basic dietary supplement usage, rising prevalence of gastrointestinal disorders.
The lactobacillus fermentum market size is expected to see strong growth in the next few years. It will grow to $1.22 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to rising demand for personalized nutrition and microbiome based therapies, increasing adoption of preventive healthcare and functional foods, expansion of clinical research in probiotic therapeutics, growth in nutraceutical and dietary supplement markets, technological advancements in fermentation and strain optimization. Major trends in the forecast period include probiotic based personalized gut microbiome modulation and therapeutic nutrition solutions, fermented functional food innovation using lactobacillus strains for immunity enhancement, precision nutraceutical development driven by microbiome profiling and bioinformatics, sustainable fermentation based production processes for probiotic ingredients, integration of probiotic formulations in preventive healthcare and clinical nutrition programs.
The expansion of functional foods and beverages is expected to drive the growth of the Lactobacillus fermentum market going forward. Functional foods and beverages are products fortified with bioactive ingredients that deliver health benefits beyond basic nutrition, including supporting immunity, digestive health, and overall well-being. The demand for functional foods and beverages is increasing as rising health awareness encourages consumers to choose products that offer additional wellness benefits beyond essential nutrition. Lactobacillus fermentum contributes to functional foods and beverages by serving as a probiotic that promotes gut health, enhances digestion, and strengthens immune function, making it a valuable ingredient in wellness-focused products. For instance, in July 2025, according to Foodmanufacture.co.uk, a UK-based website and media platform serving the UK's food and drink manufacturing industry, health-related preferences significantly influenced the soft drinks sector, with growth largely fueled by functional beverages such as kombucha, which recorded a 30% year-on-year increase, while health shots containing ingredients such as ginger and turmeric surged by 92% year-on-year for the week ending 22 February 2025. Therefore, the expansion of functional foods and beverages is driving the growth of the Lactobacillus fermentum market.
The increasing prevalence of gastrointestinal disorders is expected to drive the growth of the Lactobacillus fermentum market going forward. Gastrointestinal disorders are conditions that affect the digestive tract and interfere with normal digestion and bowel function. The prevalence of gastrointestinal disorders is rising primarily due to the growing consumption of processed, low-fiber foods, which disturb gut microbiota and negatively impact digestive health. Lactobacillus fermentum supports the management of gastrointestinal disorders by restoring the balance of gut microbiota, suppressing harmful bacteria, and improving digestion, thereby helping to alleviate symptoms such as bloating, diarrhea, and inflammation. For instance, in February 2025, according to Crohn's & Colitis Australia, an Australia-based national organization, the projected prevalence of inflammatory bowel disease (IBD) in Australia is expected to rise from 20,511,881 cases in 2023 to 23,067,771 cases by 2030. Therefore, the increasing prevalence of gastrointestinal disorders is driving the growth of the Lactobacillus fermentum market.
The growing adoption of vegan and plant-based diets is expected to drive the growth of the Lactobacillus fermentum market going forward. A vegan diet excludes all animal-derived products, while a plant-based diet primarily emphasizes foods of plant origin but may include limited amounts of animal products depending on individual preferences. The adoption of vegan and plant-based diets is increasing mainly because of greater health awareness, with more individuals embracing these dietary patterns to lower disease risk and enhance overall health. Lactobacillus fermentum supports vegan and plant-based diets by promoting gut health, improving the digestion of plant fibers, and helping maintain a healthy gut microbiome in diets that are rich in fiber-based plant foods. For instance, in April 2024, according to Finder, a US-based personal finance comparison website, around 2.5 million people in the UK were vegan, representing 4.7% of the population, compared with 1.4 million vegans (2.5%) in 2023. This reflects an increase of 1.1 million vegans in the UK between 2023 and 2024. Therefore, the growing adoption of vegan and plant-based diets is driving the growth of the Lactobacillus fermentum market.
Major companies operating in the lactobacillus fermentum market report are Meteoric Biopharmaceuticals Limited, Green Jeeva LLC, Probi AB, Unique Biotech Limited, Synbio Tech Incorporated, BioGrowing Co. Ltd., Jiangsu Wecare Biotechnology Co. Ltd., Biovencer Healthcare Private Limited, Probiotical S.p.A., Probioway Co. Ltd., Bioven Ingredients, Advenza, Lallemand Health Solutions Inc., Kerry Group plc, Rudra Bioventures Private Limited, Sapra Healthcare, Kiwla, Alpspure Lifesciences Private Limited, A. M. Nutratech Private Limited, THT S.A., BioFerScience Inc., Herbal Creations, BOC Sciences, International Flavors & Fragrances Inc., Novonesis, ADM, Kaneka Corporation
North America was the dominating region in the Lactobacillus fermentum market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the lactobacillus fermentum market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the lactobacillus fermentum market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The Lactobacillus fermentum market consists of sales of probiotic dietary supplements, functional beverages, and cosmetic and skincare products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Lactobacillus Fermentum Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses lactobacillus fermentum market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for lactobacillus fermentum ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lactobacillus fermentum market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.